45
Participants
Start Date
September 30, 2009
Primary Completion Date
June 30, 2011
Study Completion Date
February 28, 2013
Bendamustine
Bendamustine at the dose of 120 mg/m2 IV over 60 minutes on days 1 and 2 every 21 days for 6 cycles
Dr Gandhi DAMAJ, Amiens
Collaborators (1)
Mundipharma Pte Ltd.
INDUSTRY
French Innovative Leukemia Organisation
OTHER